FrancophonIA/ELRC3.0 huggingface dataset:
English: If you are being treated with an ACE-inhibitor together with certain other medicines to treat your heart failure, which are known as mineralocorticoid receptors antagonists (MRA) (for example spironolactone, eplerenone) or betablockers (for example metoprolol).”
Maltese: Jekk qed tiġi kkurat b'inibitur ta' ACE flimkien ma' ċerti mediċini oħrajn biex jikkuraw l-insuffiċjenza tal-qalb tiegħek, li huma magħrufa bħala antagonisti tar-riċetturi mineralokortikojdi (MRA) (pereżempju spironolactone, eplerenone) jew imblokkaturi tar-riċetturi beta (pereżempju metoprolol).”
English: This combination apparently increases the risk for adverse events and is therefore not recommended.
Maltese: Din il-kombinazzjoni apparentement iżżid ir-riskju ta' avvenimenti avversi u għalhekk mhijiex rakkomandata.
English: These medicines are for the treatment of heart failure (see “Other medicines and X”).”
Maltese: Dawn il-mediċini huma għall-kura ta' insuffiċjenza tal-qalb (ara “Mediċini oħra u X”).
English: Evaluation of patients with heart failure should always include assessment of renal function (see section 4.2).
Maltese: L-evalwazzjoni ta' pazjenti b'insuffiċjenza tal-qalb għandha dejjem tinkludi evalwazzjoni tal-funzjoni tal-kliewi (ara sezzjoni 4.2).
English: Cardiovascular death and stroke were both numerically more frequent in the aliskiren group than in the placebo group and adverse events and serious adverse events of interest (hyperkalaemia, hypotension and renal dysfunction) were more frequently reported in the aliskiren group than in the placebo group.”
Maltese: Mewt kardjovaskulari u puplesija t-tnejn kienu numerikament iktar frekwenti fil-grupp ta' aliskiren milli fil-grupp tal-plaċebo, u avvenimenti avversi u avvenimenti avversi serji ta' interess (iperkalimja, pressjoni baxxa u disfunzjoni tal-kliewi) ġew irrappurtati b'mod iktar frekwenti fil-grupp ta' aliskiren milli fil-grupp tal-plaċebo.”
English: “Concomitant therapy with an ACE-inhibitor in heart failure
Maltese: “Terapija fl-istess ħin b'inibitur ta' ACE f'insuffiċjenza tal-qalb
English: Section 4.2 - Posology and method of administration For angiotensin II receptor blockers with wording in section 4.2 stating that they can be used alone or in combination with other antihypertensive agents, the following cross-reference should be added: “(see sections 4.3, 4.4, 4.5 and 5.1)”.
Maltese: Sezzjoni 4.2 - Pożoloġija u metodu ta' kif għandu jingħata Il-cross-reference li ġejja għandha tiżdied fis-sezzjoni “Pożoloġija fi Pressjoni Għolja”: “(ara sezzjonijiet 4.3, 4.4, 4.5 u 5.1)”
English: - aliskiren”
Maltese: “Insuffiċjenza tal-qalb
English: • “if you are taking any of the following medicines used to treat high blood pressure: - an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetesrelated kidney problems.
Maltese: • “jekk qed tieħu xi waħda minn dawn il-mediċini li ġejjin li jintużaw għal kura ta' pressjoni taddemm għolja: - inibitur ta' ACE (pereżempju enalapril, lisinopril, ramipril), b'mod partikulari jekk għandek problemi tal-kliewi relatati mad-dijabete. - aliskiren
English: The risk of adverse reactions, especially hypotension, hyperkalaemia and decreased renal function (including acute renal failure), may increase when [Product name] is used in combination with an ACEinhibitor.
Maltese: Ir-riskju ta' reazzjonijiet avversi, speċjalment pressjoni baxxa, iperkalimja u tnaqqis fil-funzjoni talkliewi (li jinkludi insuffiċjenza akuta tal-kliewi), jista' jiżdied meta [Isem tal-prodott] jintuża flimkien ma' inibitur ta' ACE.
English: Valsartan may be administered with other heart failure therapies.
Maltese: Valsartan jista' jingħata ma' terapiji oħrajn kontra l-insuffiċjenza tal-qalb.
English: - If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not <take> <use> X” and “Warnings and precautions”) - If you are being treated with an ACE-inhibitor together with certain other medicines to treat your heart failure, which are known as mineralocorticoid receptors antagonists (MRA) (for example spironolactone, eplerenone).”
Maltese: - Jekk qed tiġi kkurat b'inibitur ta' ACE flimkien ma' ċerti mediċini oħrajn biex jikkuraw l-insuffiċjenza tal-qalb tiegħek, li huma magħrufa bħala antagonisti tar-riċetturi mineralokortikojdi (MRA) (pereżempju spironolactone, eplerenone)”
English: • “if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren”
Maltese: • “jekk għandek id-dijabete jew funzjoni tal-kliewi indebolita u qed tiġi kkurat b'mediċina li tbaxxi l-pressjoni tad-demm li fiha aliskiren”
English: As valsartan is an angiotensin II receptor blocker, it cannot be excluded that the use of [Product name] may be associated with impairment of the renal function.
Maltese: Billi valsartan hu imblokkatur tar-riċetturi ta' angiotensin II, ma jistax jiġi eskluż li l-użu ta' [Isem tal-prodott] jista' jiġi assoċjat ma' indeboliment tal-funzjoni tal-kliewi.
English: The following contraindication should be reflected in this section: “The concomitant use of [Product name] with an ACE-inhibitor or an angiotensin II receptor blocker is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.4, 4.5 and 5.1).”
Maltese: Il-kontraindikazzjoni li ġejja għandha tiġi riflessa f'din is-sezzjoni: “L-użu fl-istess ħin ta' [Isem tal-prodott] ma' inibitur ta' ACE jew imblokkatur tar-riċetturi ta' angiotensin II hu kontraindikat f'pazjenti b'dijabete mellitus jew indeboliment tal-kliewi (GFR ta' < 60 ml/min/1.73m2) (ara sezzjonijiet 4.4, 4.5 u 5.1).” Sezzjoni 4.4 - Twissijiet speċjali u prekawzjonijiet għall-użu Il-kitba li ġejja għandha tiġi riflessa f'din is-sezzjoni: “Imblokk doppju tas-sistema renin-angiotensin-aldosterone:
English: Section 4.4 - Special warnings and precautions for use The following wording should be reflected in this section: “Dual blockade of the renin-angiotensin-aldosterone-system (RAAS) Hypotension, syncope, stroke, hyperkalaemia and decreased renal function (including acute renal failure) have been reported in susceptible individuals, especially if combining medicinal products that affect this system (see section 5.1).
Maltese: (RAAS) Pressjoni baxxa, sinkope, puplesija, iperkalimja u tnaqqis fil-funzjoni tal-kliewi (li jinkludi insuffiċjenza akuta tal-kliewi) ġew irrappurtati f'individwi suxxettibbli, speċjalment jekk tkun qed tintuża kombinazzjoni ta' prodotti mediċinali li jaffettwaw lil din is-sistema (ara sezzjoni 5.1).
English: In patients whose renal function may depend on the activity of the renin-angiotensin-aldosteronesystem (e.g. patients with severe congestive heart failure), treatment with ACE-inhibitors has been associated with oliguria and/or progressive azotaemia and in rare cases with acute renal failure and/or death.
Maltese: F'pazjenti li l-funzjoni tal-kliewi tagħhom tista' tiddependi fuq l-attività tas-sistema renin-angiotensinaldosterone (eż. pazjenti b'insuffiċjenza konġestiva severa tal-qalb), il-kura b'inibituri ta' ACE ġiet assoċjata ma' oligurija u/jew ażotaemija progressiva, u f'każijiet rari, ma' insuffiċjenza akuta tal-kliewi u/jew mewt.
English: Ref. EMEA/156698/2009
Maltese: EMEA/291372/2009
English: London, 19 March 2009 Doc.
Maltese: Londra, 19 ta' Marzu 2009 Dok ta' Ref.
English: What is Cylatron?
Maltese: X'inhu Cylatron?
English: International non-proprietary name (INN): peginterferon alfa-2b
Maltese: Denominazzjoni Komuni Internazzjonali (DKI): peginterferon alfa-2b
English: It contains the active substance peginterferon alfa-2b.
Maltese: Fih is-sustanza attiva peginterferon alfa-2b.
English: It consists of a substance called interferon alfa-2b, which has been ‘pegylated' (coated with a chemical called polyethylene glycol).
Maltese: Din tikkonsisti f'sustanza msejħa interferon alfa-2b, li ġiet ‘pegylated' (jiġifieri miksija b'sustanza kimika msejħa polyetilene glikol [polyethylene glycol]).
English: The active substance in Cylatron, peginterferon alfa-2b, belongs to the group ‘interferons'.
Maltese: Is-sustanza attiva f'Cylatron, peginterferon alfa-2b, tappartjeni għall-grupp ta' ‘interferoni'.
English: The CHMP normally takes up to 210 days to evaluate a new application.
Maltese: Is-CHMP normalment jieħu sa 210 ġranet biex jevalwa applikazzjoni ġdida.
English: How far into the evaluation was the application when it was withdrawn?
Maltese: Sa fejn kienet waslet l-evalwazzjoni tal-applikazzjoni meta din ġiet irtirata?
English: Cylatron was studied in one main study involving 1,256 adults with stage III melanoma.
Maltese: Cylatron ġie studjat fi studju ewlieni wieħed li kien jinvolvi 1,256 adult b'melanoma ta' fażi
English: On 11 March 2009, SP Europe officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Cylatron for the adjuvant treatment of stage III melanoma.
Maltese: Fil-11 ta' Marzu 2009, SP Europe għarrfet uffiċjalment lill-Kumitat għall-Prodotti Mediċinali għallUżu mill-Bniedem (CHMP) bl-intenzjoni li tirtira l-applikazzjoni tagħha għall-awtorizzazzjoni għattqegħid fis-suq għal Cylatron għat-trattament addizzjonali ta' melanoma ta' fażi
English: Peginterferon alfa-2b has been authorised in the European Union (EU) since May 2000 as PegIntron and ViraferonPeg for the treatment hepatitis C. Unpegylated interferon alfa-2b has also been authorised in the EU since March 2000 as IntronA.
Maltese: Peginterferon alfa-2b ilu awtorizzat fl-Unjoni Ewropea (UE) sa minn Mejju tas-sena 2000 bħala PegIntron u ViraferonPeg għat-trattament tal-epatite Ċ.
English: The CHMP had concerns over side effects of Cylatron, particularly fatigue (tiredness) and depression.
Maltese: Is-CHMP wera tħassib dwar l-effetti sekondarji ta' Cylatron, b'mod partikolari l-għeja u ddepressjoni.
English: What is happening with PegIntron and ViraferonPeg for the treatment of hepatitis C and with IntronA for the treatment of malignant melanoma?
Maltese: X'jiġri b'PegIntron u b'ViraferonPeg għat-trattament tal-epatite Ċ u b'IntronA għattrattament tal-melanoma malinja?
English: How is Cylatron expected to work?
Maltese: Għal xiex kien mistenni li jintuża Cylatron?
English: IntronA is authorised for the treatment of malignant melanoma after surgery, along with other diseases.
Maltese: IntronA huwa awtorizzat għattrattament ta' melanoma malinja wara intervent kirurġiku, flimkien ma' mard ieħor.
English: Questions and answers on the withdrawal of the marketing application for Cylatron
Maltese: Mistoqsija u tweġiba dwar l-irtirar tal-applikazzjoni għat-tqegħid fis-suq għal Cylatron
English: Cylatron is a powder and solvent that is made up into a solution for injection.
Maltese: Cylatron huwa trab u solvent li jitħalltu biex isiru soluzzjoni għall-injezzjoni.
English: The effects of Cylatron were first tested in experimental models before being studied in humans.
Maltese: L-effetti ta' Cylatron għall-ewwel ġew ittestjati fuq mudelli sperimentali qabel ma ġew studjati fuq ilbniedem.
English: After the CHMP had assessed the responses from the company to a list of questions, there were still some unresolved issues outstanding.
Maltese: Wara li s-CHMP kien ivvaluta ttweġibiet mill-kumpanija għal lista ta' mistoqsijiet, kien għad baqa' xi kwistjonijiet pendenti li baqgħu ma ġewx solvuti.
English: Based on the review of the data and the company's response to the CHMP list of questions at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Cylatron could not have been approved for adjuvant treatment of stage III melanoma.
Maltese: Skont l-analiżi tad-dejta u t-tweġiba mogħtija mill-kumpanija għal-lista ta' mistoqsijiet tas-CHMP fiżżmien tal-irtirar, is-CHMP ma kellu l-ebda tħassib u kien tal-opinjoni provviżorja li Cylatron ma setax jiġi approvat għat-trattament addizzjonali tal-melanoma ta' fażi
English: Based on the review of the initial documentation, the CHMP prepares a list of questions at day 120, which is sent to the company.
Maltese: Fuq il-bażi tar-reviżjoni tad-dokumentazzjoni inizjali, is-CHMP jħejji lista ta' mistoqsijiet fil-jum 120, li mbagħad tintbagħat lill-kumpanija.
English: Cylatron was expected to be given to patients whose lymph nodes contained melanoma cells as visible under a microscope, but not when the cancer had caused the lymph nodes to become large enough to be felt through the skin.
Maltese: Meta beda l-istudju, il-pazjenti kollha kien sarilhom intervent kirurġiku biex jitneħħew il-linfonodi li kien fihom ċelloli tal-melanoma.
English: Cylatron was expected to be used in adults with stage III (advanced) melanoma as an add-on treatment after surgery, to prevent the disease from coming back.
Maltese: III (avvanzata) bħala trattament addizzjonali wara intervent kirurġiku, biex jipprevjeni milli l-marda terġa' titfaċċa.
English: In melanoma, interferon alfa-2b is thought to work by suppressing the growth and multiplication of cancerous cells, by causing these cells to die and by stimulating the immune system (the body's natural defences) to attack and kill the cancer cells.
Maltese: Fil-melanoma, interferon alfa-2b hija maħsuba li taħdem billi twaqqaf it-tkabbir u l-multiplikazzjoni ta' ċelloli kanċerużi, billi ġġiegħel lil dawn iċ-ċelloli jmutu u billi tistimula s-sistema immunitarja (iddifiżi naturali tal-ġisem) sabiex tattakka u toqtol liċ-ċelloli tal-kanċer.
English: Invented name Strength Pharmaceutical
Maltese: Qawwa Għamla farmaċewtika
English: Route of administration
Maltese: Mnejn jingħata
English: Box 1711
Maltese: P.O. Box 1711
English: C. G. Papaloisou Ltd. Office address:
Maltese: Papaloisou Ltd.
English: P.O.
Maltese: C.
English: Modified-release capsule, hard
Maltese: Kapsula li terħi il-mediċina b'mod modifikat, iebsa
English: Redomex
Maltese: Ċipru
English: Sarotex Retard 50 50 mg
Maltese: Saroten Tabs 50 mg
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, Marketing Authorisation Holders in the Member States
Maltese: Lista tal-ismijiet, għamliet farmaċewtiċi, qawwiet tal-prodott mediċinali, mnejn jingħata, id-detenturi tal-awtorizzazzjoni għat-tqegħid fis-suq fl istati membri
English: Coated Tablet
Maltese: Pillola miksija
English: Intramuscular use intravenous use
Maltese: Soluzzjoni għall-injezzjoni
English: Modified-release tablet
Maltese: Pillola li terħi il-mediċina b'mod modifikat
English: --1 Inactivated influenza A virus/human, strain A/Jena/VI5258/2009(H1N1)pdm09 ≥ 16 HU* *HU = haemagglutinating units
Maltese: A/Jena/VI5258/2009(H1N1)pdm09 ≥ 16 HU*
English: Annex A
Maltese: Anness A
English: Packaging Content
Maltese: Ippakkjar Kontenut Daqs talpakkett
English: Route of administration
Maltese: Mod ta' Amministrazz joni
English: EU (MA) Number Invented name
Maltese: *HU = unitajiet li jemagglutinizzaw
English: 2 Ellinikou Str 16777,Elliniko, Athens Greece
Maltese: 2 Ellinikou Str 16777,Elliniko, Athens
English: 26.200 28700 San Sebastián de los Reyes (Madrid) Spain
Maltese: 200 28700 San Sebastián de los Reyes (Madrid) Spanja
English: Mylan Sas 117, allée des Parcs 69800 Saint-Priest France
Maltese: Mylan Sas 117, allée des Parcs 69800 Saint-Priest Franza
English: 2333 CR Leiden The Netherlands
Maltese: 2333 CR Leiden L-Olanda
English: Teva Sante 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex France
Maltese: Teva Sante 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex Franza
English: Weifa AS, Hausmannsgate 6, P.O.Box 9113
Maltese: In-Norveġja Weifa AS, Hausmannsgate 6, P.O.Box 9113
English: Estrada Consiglieri Pedroso, 69 A - Queluz de Baixo 2730-055 Barcarena Portugal
Maltese: Estrada Consiglieri Pedroso, 69 A - Queluz de Baixo 2730-055 Barcarena Il-Portugall
English: Societe Cilfa Developpement 20, Rue Jean Daudin 75015 - Paris France
Maltese: Societe Cilfa Developpement 20, Rue Jean Daudin 75015 - Paris Franza
English: Barcelona Spain
Maltese: Barcelona Spanja
English: 37, rue Saint-Romain 69379 Lyon Cedex 08 France
Maltese: 37, rue Saint-Romain 69379 Lyon Cedex 08 Franza
English: Germany codeinphosphathemihydrat codi OPT
Maltese: Il-Ġermanja codeinphosphathemihydrat codi OPT
English: Actavis EAD 29 Atanas Dukov Str. + Sofia 1407
Maltese: Il-Bulgarija Actavis EAD 29 Atanas Dukov Str. + Sofia 1407
English: Belgium Aktuapharma nv Ambachtenlaan 13E 3001 Leuven
Maltese: Aktuapharma nv Ambachtenlaan 13E 3001 Leuven Il-Belġju
English: 22 quai Gallieni 92150 Suresnes France
Maltese: 22 quai Gallieni 92150 Suresnes Franza
English: 032266 Bucureşti, Romania codeinum
Maltese: 032266 Bucureşti, Ir-Rumanija codeinum
English: Tipperary, Ireland
Maltese: Tipperary, L-Irlanda
English: Bega Nr. 4, TârguMureş, 540390
Maltese: Mureş, 540390
English: Grønland, NO-0133 Oslo,
Maltese: Grønland, NO-0133
English: Belgium Mylan BVBA/SPRL Terhulpsesteenweg 6A,
Maltese: Il-Belġju Mylan BVBA/SPRL Terhulpsesteenweg 6A,
English: Belgium Sterop Laboratoires nv Avenue de Scheut 46
Maltese: Sterop Laboratoires nv Avenue de Scheut 46
English: 69151 Décines Cedex France
Maltese: 69151 Décines Cedex Franza
English: Mateo Inurria, 30 28036 Madrid Spain
Maltese: Mateo Inurria, 30 28036 Madrid Spanja
English: 92300 Levallois-Perret France
Maltese: 92300 Levallois-Perret Franza
English: 2012 HK Haarlem The Netherlands
Maltese: 2012 HK Haarlem L-Olanda
English: C/ Anabel Segura, 11 Edificio Albatros B, 1ª planta
Maltese: TEVA PHARMA, S.L.U. C/ Anabel Segura, 11 Edificio Albatros B, 1ª planta
English: 08228 Tarrasa (Barcelona) Spain
Maltese: 08228 Tarrasa (Barcelona) Spanja
English: Belgium Teva Pharma Belgium Laarstraat 16
Maltese: Il-Belġju Teva Pharma Belgium Laarstraat 16
English: 92700 Colombes France
Maltese: 92700 Colombes Franza
English: Germany Berlin-Chemie AG Glienicker Weg 125
Maltese: Il-Ġermanja Berlin-Chemie AG Glienicker Weg 125
English: Bayer Sante Familiale 33, Rue De L'industrie 74240 Gaillard France
Maltese: Bayer Sante Familiale 33, Rue De L'industrie 74240
English: Souffelweyersheim France
Maltese: Souffelweyersheim Franza
English: 69007 Lyon France
Maltese: 69007 Lyon Franza
English: Denmark Takeda Pharma A/S, Langebjerg 1, DK4000 Roskilde
Maltese: Id-Danimarka Takeda Pharma A/S, Langebjerg 1, DK4000 Roskilde
English: 851 01 Bratislava Slovak Republic
Maltese: 851 01 Bratislava
English: S.C. TERAPIA S.A Str. Fabricii Nr.124, Cluj-Napoca, Judeţul Cluj, 400632
Maltese: Fabricii Nr.124, Cluj-Napoca, Judeţul Cluj, 400632
English: 92517 Boulogne Billancourt Cedex France
Maltese: 92517 Boulogne Billancourt Cedex Franza
English: 28042 Madrid Spain
Maltese: 28042 Madrid Spanj
English: FARMALIDER, S.A. Aragoneses, 15 28108 Madrid Spain
Maltese: FARMALIDER, S.A. Aragoneses, 15 28108 Madrid Spanja
English: UCB (Pharma) Ireland Limited, United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin
Maltese: L-Irlanda UCB (Pharma) Ireland Limited, United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin
English: Germany Dr. R. Pfleger Chemische Fabrik GmbH
Maltese: Il-Ġermanja Dr. R. Pfleger Chemische Fabrik GmbH
English: The Netherlands ratiopharm Nederland B.V.
Maltese: L-Olanda ratiopharm Nederland B.V.
English: Chefaro Ireland Limited, First Floor, Block A, The Crescent Building, Northwood Office Park, Dublin 9, Ireland
Maltese: L-Irlanda Chefaro Ireland Limited, First Floor, Block A, The Crescent Building, Northwood Office Park, Dublin 9, L-Irlanda
English: Luxembourg MEDA PHARMA 25 boulevard de l'amiral Bruix F-75016 Paris France
Maltese: MEDA PHARMA 25 boulevard de l'amiral Bruix F-75016 Paris Franza
English: Omega Pharma Baltics SIA, K. Ulmana 119, Marupe, LV-2167, Latvia
Maltese: Omega Pharma Baltics SIA, K. Ulmana 119, Marupe, LV-2167, IlLatvja
English: Sweden Evolan Pharma AB Box: 120
Maltese: L-Isvezja Evolan Pharma AB Box: 120
English: Sweden Meda AB Box 906
Maltese: L-Isvezja Meda AB Box 906
English: Reckitt Benckiser (Poland) S.A.
Maltese: Il-Polonja Reckitt Benckiser (Poland) S.A.
English: Luxembourg Laboratoires SMB S.A. Rue de la Pastorale 26- 28 B 1080
Maltese: Laboratoires SMB S.A. Rue de la Pastorale 26- 28 B 1080
English: Sweden sanofi-aventis AB Box: 14142
Maltese: L-Isvezja sanofi-aventis AB Box: 14142
English: Reckitt Benckiser Ireland Ltd, 7
Maltese: L-Irlanda Reckitt Benckiser Ireland Ltd, 7
English: 170 09 Solna Sweden codeine hydrochloride dihydrate, papaverine hydrochloride, morphine hydrochloride, hyoscine methonitrate, noscapine hydrochloride
Maltese: 170 09 Solna L-Isvezja codeine hydrochloride dihydrate, papaverine hydrochloride, morphine hydrochloride, hyoscine methonitrate, noscapine hydrochloride
English: Romania codeinum
Maltese: Ir-Rumanija codeinum
English: Luxembourg Meda Pharma GmbH&Co.
Maltese: Meda Pharma GmbH&Co.
English: Denmark Alternova A/S, Lodshusvej 11, DK4230 Skælskør, Denmark
Maltese: Id-Danimarka Alternova A/S, Lodshusvej 11, DK4230 Skælskør, Id-Danimarka
English: 13500 HÄMEENLINNA Finland
Maltese: 13500 HÄMEENLINNA Il-Finlandja
English: Sweden Mundipharma AB, Mölndalsvägen 30
Maltese: L-Isvezja Mundipharma AB, Mölndalsvägen 30
English: Quintanavides, 15 28050 Madrid Spain
Maltese: Quintanavides, 15 28050 Madrid Spanja
English: Globegen Laboratories Limtied, 1406
Maltese: Ir-Renju Unit Globegen Laboratories Limtied, 1406
English: INTERNACIONAL, S.A. Gran Vía Carlos III, 94 08028 Barcelona Spain
Maltese: INTERNACIONAL, S.A. Gran Vía Carlos III, 94 08028 Barcelona Spanja
English: Sweden BioPhausia AB Blasieholmsgatan 2
Maltese: L-Isvezja BioPhausia AB Blasieholmsgatan 2
English: Panadol Ultra, Panadol Ultra Rapide
Maltese: Panadol Ultra, Panadol Ultra
English: South Devon Healthcare NHS Foundation Trust, Torbay PMU, Long Road, Paignton, Devon TQ4 7TW
Maltese: Ir-Renju Unit South Devon Healthcare NHS Foundation Trust, Torbay PMU, Long Road, Paignton, Devon TQ4 7TW
English: Luxembourg Mylan bvba/sprl Rozendal Businesspark Terhulpsesteenweg 6A B-1560 Hoeilaart Belgium
Maltese: Mylan bvba/sprl Rozendal Businesspark Terhulpsesteenweg 6A B-1560 Hoeilaart IlBelġju
English: Str. Prahova, Nr. 6A, Sector 1, Bucureşti 012423, România paracetamol, fosfat de codeină hemihidrat, cafeină anhidră
Maltese: Prahova, Nr. 6A, Sector 1, Bucureşti 012423, Ir-Rumanija paracetamol, fosfat de codeină hemihidrat, cafeină anhidră
English: Luxembourg GlaxoSmithKline Consumer Healthcare S.A. Site Apollo avenue Pascal 2-6 B1300 Wavre
Maltese: GlaxoSmithKline Consumer Healthcare S.A. Site Apollo avenue Pascal 2-6 B1300 Wavre Il-Belġju
English: Azur compositum SC Suppositorien suppository rectal use
Maltese: Azur compositum SC Suppositorien suppożitorju użu minn ġorrektum
English: Ranbaxy Ireland Limited, Spafield, Cork Road, Cashel, Co.
Maltese: Ir-Renju Unit Ranbaxy Ireland Limited, Spafield, Cork Road, Cashel, Co.
English: Cod., suppositoria 400 mg 9.6 mg
Maltese: A.C. Cod., suppositoria 400 mg 9.6 mg
English: Str. Ştirbei Vodă Nr. 53-55, Sector 1, Bucureşti,
Maltese: Ştirbei Vodă Nr. 53-55,
English: 412 63 Göteborg Sweden ibuprofen/codeine phosphate hemihydrate
Maltese: 412 63 Göteborg L-Isvezja ibuprofen/codeine phosphate hemihydrate
English: Ireland
Maltese: Irlanda
English: 00351 Helsinki Finland
Maltese: 00351 Helsinki
English: 3 Rue Joseph Monier 92500 Rueil Malmaison France paracetamol + codeine phosphate
Maltese: 3 Rue Joseph Monier 92500 Rueil Malmaison Franza paracetamol + codeine phosphate
English: 00101 Helsinki Finland
Maltese: 00101 Helsinki
English: S.C. Bio EEL S.R.L.Str.
Maltese: Bio EEL S.R.L.Str.
English: Slovenia codeine, paracetamol, propyphenazone, caffeine
Maltese: Is-Slovenja codeine, paracetamol, propyphenazone, caffeine
English: ACTAVIS GROUP PTC EHF Reykjavikurvegur
Maltese: Ir-Renju Unit ACTAVIS GROUP PTC EHF Reykjavikurvegur
English: Coventry Road, Yardley, Birmingham B25 8AE
Maltese: Yardley, Birmingham B25 8AE
English: S.C. SINTOFARM S.A.Str.
Maltese: SINTOFARM S.A.Str.
English: Belgium Laboratoires SMB SA rue de la Pastorale 26
Maltese: Laboratoires SMB SA rue de la Pastorale 26
English: McNeil Healthcare (Ireland) Ltd, Airton Road, Tallaght, Dublin
Maltese: L-Irlanda McNeil Healthcare (Ireland) Ltd, Airton Road, Tallaght, Dublin
English: Pelplińska 19 Starogard Gdański
Maltese: Starogard Gdański
English: Omega Pharma Limited
Maltese: Il-Bulgarija Omega Pharma Limited